Literature DB >> 26724530

Protein sorting gone wrong--VPS10P domain receptors in cardiovascular and metabolic diseases.

Vanessa Schmidt1, Thomas E Willnow2.   

Abstract

VPS10P domain receptors are a unique class of sorting receptors that direct intracellular transport of target proteins in neurons and that play central roles in neurodegenerative processes. Surprisingly, genome-wide association studies now implicate the very same receptors in cardiovascular and metabolic disturbances. In this review, we discuss current findings that uncovered some of the molecular mechanisms whereby sorting receptors, such as SORLA, sortilin, and SORCS1 control homeostasis in cardiovascular and metabolic tissues, and how they promote hypercholesterolemia, atherosclerosis, obesity, and diabetes, when being altered.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cholesterol metabolism; GWAS; Lipoprotein receptors; Mouse models; Protein sorting; Risk genes; VPS10P domain receptors

Mesh:

Substances:

Year:  2015        PMID: 26724530     DOI: 10.1016/j.atherosclerosis.2015.11.027

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

Review 1.  Sortilin and Its Multiple Roles in Cardiovascular and Metabolic Diseases.

Authors:  Claudia Goettsch; Mads Kjolby; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-30       Impact factor: 8.311

2.  Maternal BMI as a predictor of methylation of obesity-related genes in saliva samples from preschool-age Hispanic children at-risk for obesity.

Authors:  Kathryn Tully Oelsner; Yan Guo; Sophie Bao-Chieu To; Amy L Non; Shari L Barkin
Journal:  BMC Genomics       Date:  2017-01-09       Impact factor: 3.969

3.  Low pH-induced conformational change and dimerization of sortilin triggers endocytosed ligand release.

Authors:  Nadia Leloup; Philip Lössl; Dimphna H Meijer; Martha Brennich; Albert J R Heck; Dominique M E Thies-Weesie; Bert J C Janssen
Journal:  Nat Commun       Date:  2017-11-22       Impact factor: 14.919

4.  SorLA in Interleukin-6 Signaling and Turnover.

Authors:  Jakob Vejby Larsen; Claus Munck Petersen
Journal:  Mol Cell Biol       Date:  2017-05-16       Impact factor: 4.272

5.  Structural insights into SorCS2-Nerve Growth Factor complex formation.

Authors:  Nadia Leloup; Lucas M P Chataigner; Bert J C Janssen
Journal:  Nat Commun       Date:  2018-07-30       Impact factor: 14.919

6.  Vps10-mediated targeting of Pep4 determines the activity of the vacuole in a substrate-dependent manner.

Authors:  Fahd Boutouja; Christian M Stiehm; Thomas Mastalski; Rebecca Brinkmeier; Christina Reidick; Fouzi El Magraoui; Harald W Platta
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

7.  Candidate Gene and Genome-Wide Association Studies for Circulating Leptin Levels Reveal Population and Sex-Specific Associations in High Cardiovascular Risk Mediterranean Subjects.

Authors:  Carolina Ortega-Azorín; Oscar Coltell; Eva M Asensio; Jose V Sorlí; José I González; Olga Portolés; Carmen Saiz; Ramon Estruch; Judith B Ramírez-Sabio; Alejandro Pérez-Fidalgo; Jose M Ordovas; Dolores Corella
Journal:  Nutrients       Date:  2019-11-13       Impact factor: 5.717

8.  Evidence of vascular endothelial dysfunction in Wooden Breast disorder in chickens: Insights through gene expression analysis, ultra-structural evaluation and supervised machine learning methods.

Authors:  Behnam Abasht; Michael B Papah; Jing Qiu
Journal:  PLoS One       Date:  2021-01-04       Impact factor: 3.240

9.  DeepLoc 2.0: multi-label subcellular localization prediction using protein language models.

Authors:  Vineet Thumuluri; José Juan Almagro Armenteros; Alexander Rosenberg Johansen; Henrik Nielsen; Ole Winther
Journal:  Nucleic Acids Res       Date:  2022-04-30       Impact factor: 19.160

Review 10.  Ubiquitin-like processing of TUG proteins as a mechanism to regulate glucose uptake and energy metabolism in fat and muscle.

Authors:  Jonathan S Bogan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.